Donogh P O'Brien

Title: Donogh P O'Brien: Innovator in Coagulation Disorder Treatments

Introduction

Donogh P O'Brien is a notable inventor based in Harrow, GB. He has made significant contributions to the field of medicine, particularly in the treatment of coagulation disorders. With a total of 4 patents to his name, O'Brien's work has the potential to impact many lives.

Latest Patents

O'Brien's latest patents include innovative methods for treating coagulation disorders. One of his key inventions is a method for the treatment of coagulation disorders using lipoprotein associated coagulation inhibitor (LACI). This invention focuses on a therapeutic composition that involves the administration of LACI to address these disorders effectively. Another significant patent involves methods of neutralizing coagulation with anti-tissue factor antibodies. This invention is particularly relevant for treating myocardial infarction and includes methods for neutralizing coagulation in patients with deep vein thrombosis.

Career Highlights

Throughout his career, O'Brien has been associated with Genentech, Inc., a leading biotechnology company. His work at Genentech has allowed him to collaborate with other experts in the field and contribute to groundbreaking research and development.

Collaborations

Some of O'Brien's notable coworkers include Gordon A Vehar and Josiah N Wilcox. Their collaboration has likely fostered an environment of innovation and creativity, leading to advancements in their respective fields.

Conclusion

Donogh P O'Brien's contributions to the treatment of coagulation disorders through his patents highlight his role as an influential inventor. His work continues to pave the way for new therapeutic approaches in medicine.